Lipid Peroxidation (MDA) Assay Kit (Colorimetric) (ab233471)
Key features and details
- Detection method: Colorimetric
- Platform: Microplate reader
- Sample type: Adherent cells, Suspension cells, Tissue Lysate
Overview
-
Product name
Lipid Peroxidation (MDA) Assay Kit (Colorimetric)
See all Lipid Peroxidation kits -
Detection method
Colorimetric -
Sample type
Adherent cells, Suspension cells, Tissue Lysate -
Product overview
Lipid Peroxidation (MDA) Assay Kit (Colorimetric) ab233471 enables researchers to detect MDA without the heating steps required by the TBARS assay conventionally used for MDA detection.
In this MDA assay, the MDA Color Reagent reacts with MDA to generate a blue color product which is measured at 695 nm with absorbance microplate readers. The assay is very fast and specific for MDA with little interference from other aldehydes.
Alternatively, see our popular TBARS assay kit for MDA measurement ab118970.
MDA assay protocol summary for ab233471:
- add samples and standards to wells
- add MDA color reagent and incubate for 10-30 min at room temp
- add reaction solution and incubate for 30-60 min at room temp
- analyze with microplate reader -
Notes
Lipid peroxidation is characterized by the oxidative degradation of unsaturated fatty acids, phospholipids, glycolipids, cholesterol esters and cholesterol. Malondialdehyde (MDA) is one of the most commonly used biomarkers for lipid peroxidation.
Running an MDA assay has historically relied on a reaction with thiobarbituric acid (the TBARS assay) to generate a product that can be measured colorimetrically at 532 nm or fluorimetrically at Ex/Em = 530/550 nm.
However, the TBARS assay has quite a few limitations:
- the reaction is not specific to MDA,
- the TBA-MDA reaction needs be run under acidic conditions,
- the TBARS assay needs be run under high temperature, commonly at 90-100 ºC. -
Tested applications
Suitable for: Functional Studiesmore details -
Platform
Microplate reader
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 200 tests Dilution Buffer 1 x 10ml MDA Color Reagent 1 vial MDA Standard 1 vial Reaction Solution 1 x 10ml
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab233471 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Functional Studies |
Use at an assay dependent concentration.
|
Notes |
---|
Functional Studies
Use at an assay dependent concentration. |
Images
Datasheets and documents
-
SDS download
-
Datasheet download
References (16)
ab233471 has been referenced in 16 publications.
- Wang X et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B 12:708-722 (2022). PubMed: 35256941
- Gad El-Hak HN et al. Methanolic Phoenix dactylifera L. Extract Ameliorates Cisplatin-Induced Hepatic Injury in Male Rats. Nutrients 14:N/A (2022). PubMed: 35268000
- Yang Y et al. The Activation of AMPK/NRF2 Pathway in Lung Epithelial Cells Is Involved in the Protective Effects of Kinsenoside on Lipopolysaccharide-Induced Acute Lung Injury. Oxid Med Cell Longev 2022:3589277 (2022). PubMed: 35340214
- Wen C et al. GSK3ß Exacerbates Myocardial Ischemia/Reperfusion Injury by Inhibiting Myc. Oxid Med Cell Longev 2022:2588891 (2022). PubMed: 35528516
- Zhu X et al. Neuroprotective Effect of E3 Ubiquitin Ligase RNF8 Against Ischemic Stroke via HDAC2 Stability Reduction and Reelin-Dependent GSK3ß Inhibition. Mol Neurobiol 59:4776-4790 (2022). PubMed: 35622272